Deutsche Bank lowered the firm’s price target on CVS Health to $63 from $64 and keeps a Hold rating on the shares. The company guided down again in Q2, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health price target lowered to $62 from $65 at Evercore ISI
- CVS Health price target lowered to $63 from $65 at Barclays
- CVS Health price target raised to $62 from $58 at Cantor Fitzgerald
- Net Lease Office sells office property leased to CVS Health for $71.5M
- Disney, CVS headline busy day of earnings: Wednesday Buzz